Remove 2001 Remove Biophysical Assays Remove Computational Chemistry Remove Pharmaceuticals
article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

For example, in the screening stage of a project we are trying to find initial starting points for optimisation by our medicinal and computational chemistry colleagues. Capivasertib originated from a collaboration between my former company Astex Pharmaceuticals and the ICR and was further developed by AstraZeneca.